Insights

Innovative Delivery Technology BIOLYPH's proprietary LyoSpheres™ and ReActivator™ systems offer highly stable, easy-to-use reagent delivery solutions that improve shelf life and reduce contamination, presenting a compelling value proposition for companies seeking reliable diagnostic or biotech reagents.

Growing Market Presence With a revenue range of 10 to 25 million dollars and recent collaborations like the partnership with XCR Diagnostics for COVID-19 testing, BIOLYPH is expanding its application scope and gaining visibility in the diagnostics sector.

Customization Capabilities The company's ability to convert unstable reagents into consistent lyophilized forms and package them within disposable delivery devices allows for high levels of product customization, opening opportunities across various biotech and medical device markets.

Industry Focus Specializing in biopharmaceutical research tools and reagent stabilization, BIOLYPH targets biotech firms, diagnostic labs, and pharmaceutical manufacturers that require shelf-stable, contamination-free reagents for sensitive applications.

Technological Edge Leveraging modern tech stack components like Ubuntu, Google Analytics, and cloud hosting positions BIOLYPH to optimize digital outreach and customer engagement, creating pathways for targeted sales and partnerships.

Similar companies to BIOLYPH

BIOLYPH Tech Stack

BIOLYPH uses 7 technology products and services including SWFObject, Ubuntu, Google Analytics, and more. Explore BIOLYPH's tech stack below.

  • SWFObject
    Miscellaneous
  • Ubuntu
    Operating Systems
  • Google Analytics
    Web Analytics
  • DigitalOcean Web Hosting
    Web Hosting
  • OpenSSL
    Web Server Extensions
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

BIOLYPH's Email Address Formats

BIOLYPH uses at least 1 format(s):
BIOLYPH Email FormatsExamplePercentage
FLast@biolyph.comJDoe@biolyph.com
89%
Last@biolyph.comDoe@biolyph.com
5%
First@biolyph.comJohn@biolyph.com
3%
First_Last@biolyph.comJohn_Doe@biolyph.com
3%

Frequently Asked Questions

Where is BIOLYPH's headquarters located?

Minus sign iconPlus sign icon
BIOLYPH's main headquarters is located at 4275 Norex Dr, Chaska, Minnesota 55318, US. The company has employees across 1 continents, including North America.

What is BIOLYPH's phone number?

Minus sign iconPlus sign icon
You can contact BIOLYPH's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIOLYPH's official website and social media links?

Minus sign iconPlus sign icon
BIOLYPH's official website is biolyph.com and has social profiles on LinkedIn.

How much revenue does BIOLYPH generate?

Minus sign iconPlus sign icon
As of October 2025, BIOLYPH's annual revenue is estimated to be $2M.

What is BIOLYPH's SIC code NAICS code?

Minus sign iconPlus sign icon
BIOLYPH's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOLYPH have currently?

Minus sign iconPlus sign icon
As of October 2025, BIOLYPH has approximately 51 employees across 1 continents, including North America. Key team members include Founder, Managing Director & Governor: T. E. P.Owner: T. P.Director, Commercial Development: D. S. M.. Explore BIOLYPH's employee directory with LeadIQ.

What industry does BIOLYPH belong to?

Minus sign iconPlus sign icon
BIOLYPH operates in the Biotechnology Research industry.

What technology does BIOLYPH use?

Minus sign iconPlus sign icon
BIOLYPH's tech stack includes SWFObjectUbuntuGoogle AnalyticsDigitalOcean Web HostingOpenSSLApache HTTP ServerApache.

What is BIOLYPH's email format?

Minus sign iconPlus sign icon
BIOLYPH's email format typically follows the pattern of FLast@biolyph.com. Find more BIOLYPH email formats with LeadIQ.

When was BIOLYPH founded?

Minus sign iconPlus sign icon
BIOLYPH was founded in 1993.

BIOLYPH

Biotechnology ResearchUnited States51-200 Employees

BIOLYPH has the production processes to convert manufacturers’ unstable reagents into stable LyoSpheres™ and the disposable devices to deliver rehydrated lyophilized reagents.

LyoSpheres™ are microliter aliquots of reagents that are lyophilized as precise and durable spheres and packaged inside most delivery devices.  This capability allows incompatible reagents to coexist compatibly in a shelf-stable environment while awaiting rehydration.

BIOLYPH has also developed a line of Lyophilized Reagent Delivery Systems named ReActivator™.  ReActivator™ incorporates manufacturers’ preportioned lyophilized reagents and diluents together inside an easy-to-use, disposable, unit-of-use rehydrating dispenser providing your customers with convenient, precise, contaminant-free reagents.

Section iconCompany Overview

Headquarters
4275 Norex Dr, Chaska, Minnesota 55318, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1993
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    BIOLYPH's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    BIOLYPH's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.